Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test

Newsylist Editorial Desk. (2026, September 8, 2026). Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-09-08/novartis-stock-slides-as-centerpiece-of-12b-avidity-buyout-flunks-crucial-phase

@online{newsylist_48933,
  author = {Newsylist Editorial Desk},
  title = {{Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-09-08/novartis-stock-slides-as-centerpiece-of-12b-avidity-buyout-flunks-crucial-phase},
  note = {Tracked across 4 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test](https://www.newsylist.com/trend/2026-09-08/novartis-stock-slides-as-centerpiece-of-12b-avidity-buyout-flunks-crucial-phase)), this event was corroborated across 4 independent sources with a live velocity of 3.